C ARDIOPULMONARY BYPASS (CPB) exposes blood to
large areas of synthetic materials that trigger the production and release of numerous chemotactic and vasoactive substances. 1 Activation of neutrophils, with subsequent trapping in the pulmonary circulation, causes profound pulmonary endothelial, epithelial, and interstitial damage. 2, 3 This damage may contribute to increases in pulmonary capillary endothelial permeability, decreases in lung compliance, and impaired gas exchange. [4] [5] [6] Data indicate that conventional mechanical ventilation with tidal volumes of 10 to 15 mL/kg may damage the lungs because of regional pulmonary overdistention related to high ventilatory volumes and pressures. [7] [8] [9] [10] Patients with pulmonary dysfunction, such as adult respiratory distress syndrome (ARDS), may be more susceptible to such damage. 7, 9 Protective mechanical ventilation, with decreased tidal volumes and decreased airway pressures, may prevent such damage and has been shown to clinically benefit patients with ARDS. 7, 9 The relationship between ventilatory management and possible prevention of the damaging pulmonary effects of CPB has been investigated in animals and humans using a variety of endpoints. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] These investigations have focused only on ventilatory management of the lungs during CPB, however. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] To date, no investigation has examined the possible beneficial effects of protective ventilation in patients exposed to CPB. This prospective, randomized clinical study investigated the possible pulmonary benefits of protective ventilation in patients undergoing elective coronary artery bypass graft (CABG) surgery and early extubation.
METHODS
After Institutional Review Board approval and informed consent, 25 patients scheduled for elective CABG surgery and early tracheal extubation participated in the study. At this institution, all patients scheduled for elective CABG surgery are candidates for early extubation, including those undergoing reoperations and those with decreased left ventricular function (ejection fraction Ͻ40%). Patients who had undergone previous lung surgery were excluded from participation. Patients requiring preoperative intravenous inotropic or vasoactive drugs, intraaortic balloon support, supplemental oxygen, or mechanical ventilation were excluded.
Before arriving in the operating room, each patient was randomized to one of 2 groups by a random numbers table. Patients randomized to group CV (conventional ventilation) received mechanical ventilation parameters of respiratory rate, 8 breaths/min; tidal volume, 12 mL/kg; fraction of inspired oxygen (F I O 2 ), 1.0; and positive end-expiratory pressure (PEEP) ϩ5, after tracheal intubation; whereas group PV (protective ventilation) received mechanical ventilation parameters of respiratory rate, 16 breaths/min; tidal volume, 6 mL/kg; F I O 2 , 1.0; and PEEP, ϩ5, after tracheal intubation. In both groups, the inspiratory/ expiratory ratio was 1:3, and the inspiratory flow was adjusted so that the calculated tidal volume was delivered during the entire inspiratory cycle (creating the lowest peak airway pressure).
Each mode of ventilation (conventional or protective) was used during the entire intraoperative period and during the first hour after arrival in the intensive care unit (ICU). In both groups, the lungs were allowed to deflate during CPB. After 1 hour following ICU arrival (and after last data collection time), all patients received mechanical ventilation parameters of respiratory rate, 10 breaths/min; tidal volume, 8 mL/kg; F I O 2 , 1.0; and PEEP, ϩ5, and were weaned from mechanical ventilation by the normal ICU protocol.
The intraoperative anesthetic technique was standardized and consisted of intravenous fentanyl, 20 µg/kg; midazolam, 150 µg/kg; and vecuronium. All of the fentanyl was administered before sternotomy. Regarding midazolam, approximately 70% of the calculated total dose was administered before sternotomy, and the balance was administered during rewarming. If required, inhaled isoflurane, intravenous nitroglycerin, or both were used for blood pressure control before initiation of CPB. Hypothermic CPB (to a lowest temperature of 26°C) with a membrane oxygenator and crystalloid prime (2.0 L of lactated Ringer's solution, 50 mEq of sodium bicarbonate) was used in all patients. Nonpulsatile flows were maintained at 2.4 to 2.8 L/min/m 2 , and, if needed, isoflurane was used by the perfusionist to maintain perfusion pressure at 50 to 70 mm Hg. Alpha-stat blood gas management was used in all patients. Separation from CPB was facilitated with intravenous inotropic or vasoactive drugs at the discretion of the anesthesiologist managing the case.
Peak airway pressure, plateau airway pressure, dynamic lung compliance, static lung compliance, alveolar-arterial (A-a) oxygen gradient, arterial PCO 2 , shunt, and deadspace were determined twice perioperatively: 10 minutes after intubation (time A) and 60 minutes after ICU arrival (time B). Derived variables were determined using standard equations (see Appendix). A pulmonary artery catheter (Swan-Ganz Thermodilution Paceport Catheter, Baxter Healthcare Corporation, Irvine, CA) was used to facilitate data collection. Perioperative fluid balance, central venous pressures, and pulmonary artery occlusive pressures were also recorded at the same times.
After completion of the CABG procedure, patients were transferred to the ICU. Postoperative care was standardized, and tracheal extubation was accomplished at the earliest clinically appropriate time. Criteria for extubation in the ICU at this institution include an appropriate sensorium, normothermia, hemodynamic stability, adequate pulmonary function (PO 2 Ͼ 60 mmHg with F I O 2 0.4), adequate urine output, and minimal chest tube output. If a patient developed hypertension, tachycardia, or excessive movement when tracheal extubation was not yet appropriate (for any reason), the ICU nurse administered small amounts of intravenous midazolam. In patients who were not extubated within 12 hours of arrival in the ICU, the reason for prolonged intubation (eg, hemodynamic instability, oxygenation difficulties) was ascertained. Postoperative complications and treatments were recorded daily until hospital discharge.
Pearson's chi-square or Fisher's exact test was applied to categorical data. The Student t-test (two-tailed) was used to compare means between the 2 groups. A p value of Ͻ0.05 was considered statistically significant. Results are expressed as mean Ϯ 1 standard deviation unless otherwise indicated.
RESULTS
Thirteen patients were randomized to group CV, and 12 patients were randomized to group PV. Demographic and clinical characteristics and intraoperative data are presented in Tables 1 and 2 . Two patients in group CV and 3 patients in group PV had previous CABG surgery.
Perioperative pulmonary data are presented in Table 3 . Group CV ( p Ͻ 0.001) and group PV ( p ϭ 0.031) had significant postoperative increases in peak airway pressure. The mean increase in peak airway pressure in group CV was significantly larger than the mean increase in peak airway pressure in group PV (7.1 Ϯ 2.6 cm H 2 O v 2.4 Ϯ 3.4 cm H 2 O; p Ͻ 0.001). Group CV experienced significant postoperative increases in plateau airway pressure ( p ϭ 0.007), but group PV did not ( p ϭ 0.644). Peak and plateau airway pressures were similar between groups at time A but were significantly increased in group CV at time B ( p Ͻ 0.001 and p ϭ 0.020). Group CV ( p ϭ 0.001) and group PV ( p ϭ 0.018) had significant postoperative decreases in dynamic lung compliance. The mean decrease in dynamic lung compliance in group CV was significantly larger than the mean decrease in dynamic lung compliance in group PV (14.9 Ϯ 6.7 mL/cm H 2 O v 5.5 Ϯ 6.9 mL/cm H 2 O; p ϭ 0.002). Group CV experienced significant postoperative decreases in static lung compliance ( p ϭ 0.014), but group PV did not ( p ϭ 0.645). Group CV ( p ϭ 0.015) and group PV ( p ϭ 0.015) had significant postoperative increases in A-a oxygen gradient, but there was no difference between groups at time A ( p ϭ 0.604) or time B ( p ϭ 0.646). Group CV ( p ϭ 0.001) and group PV ( p Ͻ 0.001) had significant postoperative increases in arterial PCO 2 , but there was no difference between groups at time A ( p ϭ 0.054) or time B ( p ϭ 0.162). Group CV experienced significant postoperative increases in shunt ( p ϭ 0.021), but group PV did not ( p ϭ 0.265). There was no difference between groups regarding shunt at time A ( p ϭ 0.259) or time B ( p ϭ 0.949). There was no difference within or between groups in respect to perioperative deadspace. Regarding total operating room fluid balance (total intake Ϫ total output), there was no difference between group CV (ϩ780 Ϯ 783 mL) and group PV (ϩ690 Ϯ 827 mL). On ICU arrival, there was no difference between group CV and group PV regarding central venous pressure (8.5 Ϯ 2.7 mmHg v 8.8 Ϯ 3.6 mmHg) and pulmonary artery occlusive pressure (10.9 Ϯ 3.3 mmHg v 11.6 Ϯ 3.2 mmHg). One patient in group CV required postoperative mechanical ventilation for 7 days. This patient's postoperative course was complicated by substantial hemodynamic instability (requiring aortic arch intraaortic balloon support), pneumonia, and stroke, but the patient was discharged eventually to a rehabilitation center on postoperative day 49. Of the remaining 24 patients, there was no difference in extubation time between group CV and group PV (6.7 Ϯ 4.4 hours v 6.8 Ϯ 2.9 hours). Regarding total fluid balance (total intake Ϫ total output) during the first 24 postoperative hours, there was no difference between group CV (Ϫ470 Ϯ 1477 mL) and group PV (Ϫ287 Ϯ 1429 mL). One patient in group CV died on postoperative day 8. This patient had a history of asthma and required reintubation after extubation on postoperative days 1 and 7 secondary to respiratory failure and eventually experienced cardiac arrest on postoperative day 8. Of the remaining 24 patients, there was no difference in postoperative discharge day between group CV and group PV (10.8 Ϯ 12.9 days v 5.9 Ϯ 3.9 days; p ϭ 0.227).
DISCUSSION
The results of this investigation indicate that when compared with conventional mechanical ventilation, use of protective ventilation in patients undergoing elective CABG surgery attenuates postoperative increases in peak airway pressure, prevents postoperative increases in plateau airway pressure, attenuates postoperative decreases in dynamic lung compliance, prevents postoperative decreases in static lung compliance, and prevents postoperative increases in shunt. Taken together, these results indicate that protective ventilation may help attenuate the postoperative pulmonary dysfunction commonly seen in patients after undergoing CPB.
Volumes and pressures associated with conventional mechanical ventilation damage the lungs. [7] [8] [9] [10] Animal models suggest that alveolar overdistention is more damaging than increases in alveolar pressure, and PEEP may be somewhat protective. 22 Alveolar injury is thought to occur through cyclic closing and reopening of alveoli with resultant shear injury, which damages the alveolar-capillary interface, causes alterations in permeability leading to pulmonary edema, causes detrimental alterations in surfactant, and augments pulmonary inflammatory reactions. [7] [8] [9] [10] Prior lung injury (from any cause) likely makes them more susceptible to such damage. [7] [8] [9] [10] Protective mechanical 7 and improves mortality. 9 In June 1999, the National Institutes of Health/National Heart, Lung, and Blood Institute ARDS Network study comparing 6 mL/kg tidal volume with 12 mL/kg tidal volume was stopped for efficacy, with a significant survival benefit in the low tidal volume group. 8 CPB causes various abnormalities in the physical and functional properties of the lungs that initiate increases in pulmonary capillary endothelial permeability, decreases in lung compliance, and impaired gas exchange during the immediate postoperative period. [4] [5] [6] The relationship between ventilatory management and possible prevention of these damaging pulmonary effects of CPB has been investigated in animals and humans using a variety of endpoints. 11-21 These investigations have focused on ventilatory management of the lungs during CPB, however, and none has examined the possible beneficial effects of protective ventilation. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] To summarize these previous investigations, none of the 3 most commonly used methods of ventilatory management during CPB (passive deflation, continuous positive airway pressure, or continued ventilation) has proved superior. 11-21 Some investigators have shown that passive deflation, 16, 17 continuous positive airway pressure, [15] [16] [17] [18] 20 or continued ventilation 20 may be beneficial. Conversely, some investigators have shown that passive deflation, 12,13,15,18,20 continuous positive airway pressure, 13 or continued ventilation 13, 14, 16, 17, 21 may be detrimental. Other investigators have shown beneficial effects of a vital capacity maneuver performed before termination of CPB, 11 whereas others could not determine benefits of any technique. 19 Results from these previous investigations are difficult to interpret because of differing mechanical ventilation parameters, differing inhaled gas mixtures, differing CPB techniques, differing intravenous fluid balance protocols, and differing methods for assessing pulmonary function. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Detrimental postoperative pulmonary alterations in airway pressure, lung compliance, and shunt in patients after cardiac surgery have been documented by the authors' group 23,24 and others. [4] [5] [6] Such postoperative changes are likely caused by decreases in total lung capacity and functional residual capacity, atelectasis, pulmonary edema, increased inspired oxygen levels, intravenous vasodilators, and use of inhaled anesthetics, among others. 23, 24 This investigation reveals that protective ventilation may be useful in attenuating such postoperative pulmonary dysfunction. Patients who received protective ventilation had attenuated increases in airway pressure, attenuated decreases in lung compliance, and attenuated increases in shunt postoperatively. Although postoperative increases in A-a oxygen gradient were less in patients receiving protective ventilation, the difference did not reach statistical significance. Others have revealed that after cardiac surgery, a significant correlation (r ϭ 0.82) exists between shunt and A-a oxygen gradient. 4 This investigation studied a small number of low-risk patients for developing pulmonary dysfunction after undergoing CPB. Although at this institution all patients scheduled for elective CABG surgery are viewed as candidates for early extubation, all studied patients were essentially healthy and not expected to develop substantial postoperative pulmonary dysfunction that would affect extubation time, ICU time, discharge time, or mortality. Despite this situation, protective ventilation was still found to have potential beneficial effects on attenuating postoperative increases in airway pressure, decreases in lung compliance, and increases in shunt. A much larger study involving high-risk patients for developing pulmonary dysfunction after undergoing CPB is warranted. This investigation did not use optimal PEEP, which is advocated by some investigators to decrease the pulmonary damage associated with mechanical ventilation. Perhaps use of optimal PEEP with protective ventilation may further benefit patients after undergoing CPB.
In conclusion, use of protective ventilation in patients exposed to CPB attenuates postoperative increases in peak airway pressure, prevents postoperative increases in plateau airway pressure, attenuates postoperative decreases in dynamic lung compliance, prevents postoperative decreases in static lung compliance, and prevents postoperative increases in shunt. These results indicate that protective ventilation may help attenuate postoperative pulmonary dysfunction commonly observed in patients after undergoing CPB and deserves further investigation. 
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